Skip to main content
. 2011 Nov 11;6(11):e27265. doi: 10.1371/journal.pone.0027265

Figure 2. Ashwagandha i-Extract treatment and reversal of scopolamine-induced decrease in BDNF and GFAP expression in mice brain.

Figure 2

Effects of i-Extract (100, 200, 300 mg/Kg BW) on scopolamine (SC- 3 mg/Kg BW) induced decrease in mRNA (A) and protein (B) expression levels of BDNF and GFAP in mouse cerebrum. Data was quantitated and is shown as percent relative units. *denotes significant differences (P<0.05) between the SC group and i-Extract group. #denotes significant differences (P<0.05) between the control and SC group.